HCW Biologics Inc. (HCWB)
0.7352
-0.03
(-3.76%)
USD |
NASDAQ |
Nov 19, 11:08
HCW Biologics Net Income (Quarterly) : -5.942M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -5.942M |
| June 30, 2026 | -15.37M |
| March 31, 2026 | 1.256M |
| December 31, 2025 | -3.466M |
| September 30, 2025 | -4.554M |
| June 30, 2025 | -12.08M |
| March 31, 2025 | -2.197M |
| December 31, 2024 | -3.373M |
| September 30, 2024 | -3.902M |
| June 30, 2024 | -15.28M |
| March 31, 2024 | -7.468M |
| December 31, 2023 | -10.68M |
| September 30, 2023 | -4.939M |
| Date | Value |
|---|---|
| June 30, 2023 | -4.304M |
| March 31, 2023 | -5.071M |
| December 31, 2022 | -5.419M |
| September 30, 2022 | -3.914M |
| June 30, 2022 | -3.511M |
| March 31, 2022 | -2.057M |
| December 31, 2021 | -3.173M |
| September 30, 2021 | -4.095M |
| June 30, 2021 | -2.750M |
| March 31, 2021 | -2.844M |
| September 30, 2020 | -2.709M |
| June 30, 2020 | -2.778M |
| March 31, 2020 | -2.376M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -9.705M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -28.46M |
| Anixa Biosciences, Inc. | -2.625M |
| Vicapsys Life Sciences, Inc. | -0.1046M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0555M |
| Total Expenses (Quarterly) | 5.997M |
| EPS Diluted (Quarterly) | -2.827 |
| Enterprise Value | 7.585M |
| Gross Profit Margin (Quarterly) | -165.8% |
| Profit Margin (Quarterly) | -10.71K% |
| Earnings Yield | -2.61K% |
| Normalized Earnings Yield | -3183.26 |